{"database": "lobbying", "table": "lobbying_activities", "rows": [[1347685, "751ebd2d-e086-4c61-8bff-ca32dd4edd63", "Q4", "THE INGRAM GROUP LLC", 400577737, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2012, "fourth_quarter", "MMM", "Issues related to the Patient Protection and Affordable Care Act, P.L. 111-148: Medicare issues related to the Independent Payment Advisory Board (IPAB), Medicare funding issues, P.L. 112-25, the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012, H.R. 8.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2013-01-19T22:13:20.820000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1347685"], "units": {}, "query_ms": 680.551745928824, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}